← Open Payments lookup

MELISSA BROWN: Open Payments

NPI 1346923596 · SULPHUR, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,064 in 146 payments from 16 companies in 2025. Trend: 2023 $317 · 2024 $1,206 · 2025 $3,064

Food & beverage: $3,052Education: $12
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.22$546
ABBVIE INC.24$396
Vanda Pharmaceuticals Inc.9$380
Axsome Therapeutics, Inc.15$296
Neurocrine BioSciences, Inc.9$281
Teva Pharmaceuticals USA, Inc.11$279
Alkermes, Inc.21$260
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$167
Corium, LLC7$136
Takeda Pharmaceuticals U.S.A., Inc.4$83

Products named: VRAYLAR, REXULTI, FANAPT, Auvelity, INGREZZA, ARISTADA, UZEDY, CAPLYTA.

Industry payments across LA — which companies pay providers there.